Interleukin-2 as immunotherapeutic in the autoimmune diseases (2020)
Valencia, Alexy Orozco; Knirsch, Marcos Camargo; Ferro, Emer Suavinho 
; Stephano, Marco Antônio
Source: International Immunopharmacology. Unidades: ICB, FCF
Subjects: DOENÇAS AUTOIMUNES, INTERLEUCINA 2
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALENCIA, Alexy Orozco et al. Interleukin-2 as immunotherapeutic in the autoimmune diseases. International Immunopharmacology, v. 81, p. 1-6 art. 106296, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.intimp.2020.106296. Acesso em: 01 jun. 2024.APA
Valencia, A. O., Knirsch, M. C., Ferro, E. S., & Stephano, M. A. (2020). Interleukin-2 as immunotherapeutic in the autoimmune diseases. International Immunopharmacology, 81, 1-6 art. 106296. doi:10.1016/j.intimp.2020.106296NLM
Valencia AO, Knirsch MC, Ferro ES, Stephano MA. Interleukin-2 as immunotherapeutic in the autoimmune diseases [Internet]. International Immunopharmacology. 2020 ; 81 1-6 art. 106296.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.intimp.2020.106296Vancouver
Valencia AO, Knirsch MC, Ferro ES, Stephano MA. Interleukin-2 as immunotherapeutic in the autoimmune diseases [Internet]. International Immunopharmacology. 2020 ; 81 1-6 art. 106296.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1016/j.intimp.2020.106296
